Mkt Cap (₹ Cr.)
Face Value (₹)
|No.of Investor complaints pending at the beginning of the quarter||No.of Investor complaints received during the quarter||No.of Investor complaints disposed of during the quarter||No.of Investor complaints unresolved at the end of the quarter|
|Name of the Signatory||:-||Charandeep Singh Saluja|
|Designation||:-||Company Secretary and Compliance Officer|
Alembic Pharmaceuticals Ltd., incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 10127.07 Crore) operating in Pharmaceuticals sector.
Alembic Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 3533.84 Crore to Sales Value (96.54 % of Total Sales), Export Incentives which contributed Rs 88.18 Crore to Sales Value (2.40 % of Total Sales), Royalty Income which contributed Rs 30.67 Crore to Sales Value (0.83 % of Total Sales) and Other Operating Revenue which contributed Rs 7.58 Crore to Sales Value (0.20 % of Total Sales)for the year ending 31-Mar-2019.
For the quarter ended 30-06-2019, the company has reported a Consolidated sales of Rs 948.91 Crore, up 2.37 % from last quarter Sales of Rs 926.95 Crore and up 10.01 % from last year same quarter Sales of Rs 862.53 Crore Company has reported net profit after tax of Rs 119.08 Crore in latest quarter.
The company’s top management includes Dr.Archana Hingorani, Mr.Chirayu Amin, Mr.K G Ramanathan, Mr.Paresh Saraiya, Mr.Pranav Amin, Mr.Pranav Parikh, Mr.R K Baheti, Mr.Shaunak Amin. Company has K S Aiyar & Co. as its auditoRs As on 30-09-2019, the company has a total of 188,515,914 shares outstanding.